Bionano Genomics stock hits 52-week low at $4.9 amid sharp decline
Bionano Genomics Inc. (NASDAQ:BNGO) stock has tumbled to a 52-week low, touching down at $4.9 as the company faces a challenging market environment. According to InvestingPro data, the stock's RSI ...
Your environment affects how well your medications work
Figuring out how your genes and environment increase your likelihood of developing asthma, heart disease, cancer, dementia ...
Hoodline12h
MIT Chemists Smash Genomic Analysis Speed Barrier with Revolutionary AI-Powered Tool
MIT chemists use generative AI to predict 3D genomic structures quickly, a process far faster than current methods.
AI model learns generalized 'language' of regulatory genomics, predicts cellular stories
A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia ...
The Next Web12d
Genomics pioneer steps closer to dementia treatment breakthrough
ATx has created groundbreaking drugs for dementia and Alzheimer’s. The Icelandic startup just raised €26mn to advance the ...
10x Genomics (TXG) Receives a Hold from Bank of America Securities
In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on 10x Genomics (TXG – Research Report).